Clinical Trial Update: Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia [Phase 3]

View source ↗

Summary

Phase 3 trial reports on the efficacy and safety of a fixed-dose combination of valsartan 160 mg and rosuvastatin 20 mg in patients with hypertension and hyperl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertension

Drugs mentioned

• Rosuvastatin (rosuvastatin)
• VALSARTAN (Valsartan)

Snippet

Sponsor: LG Life Sciences | Conditions: Hypertension,, Hyperlipidemia | Phase 3 | Status: COMPLETED | Results posted: 2014-12-15